Company: IOBT
Filing Date: 2025-11-18
Form Type: 8-K
Source: 0001193125-25-285282
Chunk: 0

Company: IO Biotech, Inc.
Filing Date: 2025-11-18
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01.      Regulation FD Disclosure.  

Beginning on November 18, 2025, IO Biotech, Inc., a Delaware corporation (the “ Company”) will participate in the Jefferies Global Healthcare Conference (the “ Conference”). The Company has updated the corporate presentation that it intends to use at the Conference and in meetings with investors, a copy of which was posted to the Company’s website on November 18, 2025 (the “ Investor Deck”).

A copy of the Investor Deck is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

The information contained in this Current Report on Form8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.